| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.5M | -50.6% |
| R&D Expense | $141.8M | -6.3% |
| SG&A Expense | $106.4M | +51.0% |
| Operating Income | -$225.7M | -28.0% |
| Pre-tax Income | -$203.8M | +15.6% |
| Income Tax | -$1K | +0.0% |
| Net Income | -$203.8M | +15.6% |
| EPS (Basic) | -$1.72 | +32.8% |
| EPS (Diluted) | -$1.72 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $490.0M | -36.5% |
| Short-term Investments | $146.2M | +134.2% |
| Current Assets | $675.7M | -21.7% |
| Total Assets | $769.3M | -11.0% |
| Current Liabilities | $85.8M | -19.8% |
| Total Liabilities | $85.9M | -19.9% |
| Stockholders' Equity | $683.4M | -9.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$147.8M | +6.8% |
| Investing Cash Flow | -$174.9M | -178.3% |
| Financing Cash Flow | $29.5M | -95.5% |
| +32.8% |